RI
RPRX icon

Ridgewood Investments’s Royalty Pharma RPRX Stock Holding History

Ridgewood Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$208K Buy
+3,561
New +$210K 0.08% 213
2026
Q2 		– Sell
-4,555
Closed -$219K – 219
2026
Q1 		$219K Buy
+4,555
New +$199K 0.09% 202
2025
Q3 		$296K Sell
8,397
-15
-0.2% -$543 0.13% 182
2025
Q2 		$303K Sell
8,412
-11,236
-57% -$372K 0.13% 165
2025
Q1 		$612K Sell
19,648
-11,087
-36% -$351K 0.29% 99
2024
Q4 		$784K Buy
30,735
+8,913
+41% +$236K 0.38% 81
2024
Q3 		$617K Sell
21,822
-2,620
-11% -$72.6K 0.31% 94
2024
Q2 		$645K Sell
24,442
-602
-2% -$16.7K 0.32% 94
2024
Q1 		$761K Buy
25,044
+120
+0.5% +$3.54K 0.4% 78
2023
Q4 		$700K Sell
24,924
-863
-3% -$23.7K 0.41% 84
2023
Q3 		$700K Buy
25,787
+4,267
+20% +$127K 0.46% 75
2023
Q2 		$662K Buy
21,520
+14,175
+193% +$480K 0.38% 79
2023
Q1 		$265K Buy
7,345
+1,975
+37% +$73.2K 0.16% 146
2022
Q4 		$212K Sell
5,370
-302
-5% -$12.6K 0.15% 173
2022
Q3 		$228K Sell
5,672
-276
-5% -$11.8K 0.19% 151
2022
Q2 		$250K Sell
5,948
-12,852
-68% -$527K 0.2% 149
2022
Q1 		$732K Sell
18,800
-249
-1% -$9.78K 0.48% 69
2021
Q4 		$759K Buy
19,049
+543
+3% +$21.1K 0.48% 73
2021
Q3 		$669K Buy
18,506
+2,860
+18% +$111K 0.45% 74
2021
Q2 		$641K Buy
15,646
+10,223
+189% +$435K 0.41% 88
2021
Q1 		$237K Buy
+5,423
New +$257K 0.15% 168

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Ridgewood Investments's RPRX Position: Q3 2026 in Review

Ridgewood Investments opened a new position in Royalty Pharma (RPRX) in Q3 2026: 3,561 shares worth $208K. The stake represents 0.08% of the portfolio and ranks #213 among its holdings. This is a return to the name: Ridgewood Investments previously reported a position in RPRX as recently as Q1 2026.

Ridgewood Investments first reported a position in RPRX in Q1 2021 and has held it in 21 quarters since. The position peaked at $784K in Q4 2024. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Ridgewood Investments held 3,561 shares of Royalty Pharma worth $208K as of Q3 2026.
  • Royalty Pharma was a new Ridgewood Investments position in Q3 2026.
  • Royalty Pharma made up 0.08% of Ridgewood Investments's portfolio in Q3 2026, its #213 holding.
  • Ridgewood Investments first reported a position in Royalty Pharma in Q1 2021 and has held it in 21 quarters since.
  • Ridgewood Investments's Royalty Pharma position peaked at $784K in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Ridgewood Investments's 13F filing for Q3 2026, filed 5 Oct 2026.